SeaStar Medical
27 hedge funds and large institutions have $624K invested in SeaStar Medical in 2025 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 2 closing their positions.
205% more capital invested
Capital invested by funds: $205K → $624K (+$420K)
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
33% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 6
4% more funds holding
Funds holding: 26 → 27 (+1)
0.04% less ownership
Funds ownership: 0.43% → 0.39% (-0.04%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$246K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$146K |
| 3 |
Millennium Management
New York
|
+$138K |
| 4 |
TFA
Trinity Financial Advisors
Columbus,
Ohio
|
+$27K |
| 5 |
DAS
Dynamic Advisor Solutions
Phoenix,
Arizona
|
+$22.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$62.5K |
| 2 |
VF
Virtu Financial
New York
|
-$16K |
| 3 |
TWP
Tyche Wealth Partners
Plano,
Texas
|
-$15.4K |
| 4 |
Raymond James Financial
St Petersburg,
Florida
|
-$15.1K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$9.57K |
ICU Hedge Fund Activity: Q3 2025 in Review
27 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in SeaStar Medical (ICU) for Q3 2025, worth a combined $624K — up 205% from $205K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new ICU positions and 2 closed out — a net gain of 1 holder — while 8 added to existing stakes and 6 trimmed.
The largest buyer was Vanguard Group, adding an estimated $246K. The largest seller was UBS Group, cutting an estimated $62.5K.
- 27 institutional investors held SeaStar Medical (ICU) as of Q3 2025, up from 26 in Q2 2025.
- Funds reported $624K of SeaStar Medical stock for Q3 2025, up 205% quarter-over-quarter.
- 3 funds opened new SeaStar Medical positions in Q3 2025 and 2 closed out, a net change of +1 holder.
- The largest SeaStar Medical buyer in Q3 2025 was Vanguard Group, an estimated $246K added.
- The largest SeaStar Medical seller in Q3 2025 was UBS Group, an estimated $62.5K sold.
Based on aggregated 13F filings for Q3 2025.